Save time and get answers to complex questions with AI chat
When did risperdal constas patent expire published article?Pramlintide acetate price?When will tenofovir alafenide come off patent in canada?Drugpatentwatch market analysis industry today?When will a generic version of xiaflex be available?
See the DrugPatentWatch profile for orencia
Yes. Orencia (abatacept) is used to treat rheumatoid arthritis (RA). It is an immune-targeted biologic that works by modulating T-cell activation, which helps reduce inflammatory activity in RA.
Orencia is typically prescribed for people with rheumatoid arthritis whose disease is not well controlled with other treatments, including conventional disease-modifying drugs (DMARDs) and/or other RA therapies. It may be used alone or in combination with certain DMARDs depending on the treatment plan.
Orencia targets a specific step in T-cell signaling rather than blocking a single inflammatory cytokine (like TNF inhibitors do). Because of that mechanism, it’s sometimes chosen when other biologics or DMARD strategies are not effective or not tolerated.
Orencia is available in forms intended for RA treatment, commonly including an injection and an infusion option, which clinicians select based on patient needs and practical factors.
Other Questions About Orencia :